Algert Global’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.84M Sell
54,286
-4,014
-7% -$301K 0.06% 514
2025
Q4
$4.6M Buy
58,300
+7,083
+14% +$561K 0.07% 467
2025
Q3
$4.22M Buy
51,217
+46,219
+925% +$3.64M 0.07% 458
2025
Q2
$402K Sell
4,998
-15,191
-75% -$1.17M 0.01% 976
2025
Q1
$1.62M Sell
20,189
-17,324
-46% -$1.44M 0.04% 660
2024
Q4
$3.07M Sell
37,513
-1,771
-5% -$147K 0.07% 456
2024
Q3
$3.24M Buy
+39,284
New +$2.93M 0.09% 406
2024
Q2
Sell
-3,522
Closed -$261K 1556
2024
Q1
$261K Buy
+3,522
New +$245K 0.01% 916
2023
Q3
Sell
-12,700
Closed -$718K 1196
2023
Q2
$718K Buy
+12,700
New +$705K 0.03% 732
2022
Q3
Sell
-9,185
Closed -$577K 1259
2022
Q2
$577K Buy
+9,185
New +$608K 0.04% 706

Other funds holding MET

Algert Global's MET Position: Q1 2026 in Review

Algert Global reduced its MetLife (MET) stake by 6.9% in Q1 2026, selling an estimated $301K and leaving 54,286 shares worth $3.84M. The position accounts for 0.06% of the portfolio, ranked #514.

Algert Global first reported a position in MET in Q2 2022 and has held it in 10 quarters since. The position peaked at $4.6M in Q4 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Algert Global held 54,286 shares of MetLife worth $3.84M as of Q1 2026.
  • Algert Global sold 4,014 MetLife shares in Q1 2026, an estimated $301K.
  • MetLife made up 0.06% of Algert Global's portfolio in Q1 2026, its #514 holding.
  • Algert Global first reported a position in MetLife in Q2 2022 and has held it in 10 quarters since.
  • Algert Global's MetLife position peaked at $4.6M in Q4 2025.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.